Gamma-Aminobutyric Acid (Gaba) Receptors Rho (Gabrr) Gene Polymorphisms and Risk for Migraine. 2017

Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
Department of Pharmacology, University of Extremadura, Cáceres, Spain.

OBJECTIVE The possible role of gammaaminobutyric acid (GABA) in the pathogenesis of migraine has been suggested by a number of biochemical, pharmacological, neurophysiological and experimental data. We investigated the possible association between the most common single nucleotide polymorphisms (SNPs) in the GABA receptor rho1, 2, and 3 genes (GABRR1, GABRR2, and GABRR3) and the risk of developing migraine. METHODS The frequency of GABRR1 rs12200969, GABRR1 rs1186902, GABRR2 rs282129, and GABRR3 rs832032 genotypes and allelic variants were studied in a case-control association study involving 197 patients with migraine and 278 healthy controls by means of a TaqMan-based qPCR Assay. We also studied the possible influence of gender, age at onset of migraine, positive family history of migraine, presence or absence of aura, and triggering of migraine by ethanol on the frequency of the genotypes. RESULTS The frequencies of the genotypes and allelic variants of the 4 SNPs were similar in migraine patients and controls. Gender, positive family history of migraine, presence or absence of aura, and triggering of migraine attacks by ethanol did not influence the frequency of these genotypes. Carriers of the minor allele of the rs1186902 SNP showed a trend towards later onset of migraine. CONCLUSIONS The most common polymorphisms in the GABRR genes seemed to be not associated with the risk for migraine in Caucasian Spanish people, although one of them (GABRR1 rs1186902) shows a statistically significant association with the age of onset of migraine.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008881 Migraine Disorders A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) Acute Confusional Migraine,Headache, Migraine,Status Migrainosus,Abdominal Migraine,Cervical Migraine Syndrome,Hemicrania Migraine,Migraine,Migraine Headache,Migraine Variant,Sick Headache,Abdominal Migraines,Acute Confusional Migraines,Cervical Migraine Syndromes,Disorder, Migraine,Disorders, Migraine,Headache, Sick,Headaches, Migraine,Headaches, Sick,Hemicrania Migraines,Migraine Disorder,Migraine Headaches,Migraine Syndrome, Cervical,Migraine Syndromes, Cervical,Migraine Variants,Migraine, Abdominal,Migraine, Acute Confusional,Migraine, Hemicrania,Migraines,Migraines, Abdominal,Migraines, Acute Confusional,Migraines, Hemicrania,Sick Headaches,Variant, Migraine,Variants, Migraine
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
April 2018, Journal of neural transmission (Vienna, Austria : 1996),
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
July 2018, The pharmacogenomics journal,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
December 2008, BMC medical genetics,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
April 1978, Brain research,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
January 1985, Ceskoslovenska fysiologie,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
September 2007, Alternative medicine review : a journal of clinical therapeutic,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
March 1997, Neuroreport,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
February 1996, Biochimica et biophysica acta,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
July 1986, Casopis lekaru ceskych,
Elena García-Martín, and Carmen Martínez, and Mercedes Serrador, and Hortensia Alonso-Navarro, and Francisco Navacerrada, and Gara Esguevillas, and Esteban García-Albea, and José A G Agúndez, and Félix Javier Jiménez-Jiménez
January 1978, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!